NCT01684085|Unknown
Explanation About Sleep in Post Trauma Patients
Explanation About Sleep Given After Traumatic Event, and Its Effect on the Trajectory of Post Traumatic Stress Disorder (PTSD)
Loading search results
Explanation About Sleep Given After Traumatic Event, and Its Effect on the Trajectory of Post Traumatic Stress Disorder (PTSD)
Sponsor study identifier
interventional
70
1 country
1
Study Start
October 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
Not reported
Date not reportedThis study is designed to test the effect of an explanation about the first sleep following trauma exposure, on the development of Post Traumatic Stress Disorder (PTSD) in the months following the traumatic event.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 5, 2012
Actual (reported)September 12, 2012
Actual (reported)October 2012
Date type not reportedThis date has not been verified as actual or estimated.
September 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
PTSD severity as measured by CAPS
The primary outcome is PTSD severity at the end of the trial .This will be determined using the Clinician Administered PTSD Scale (CAPS), a scale with established reliability and good psychometric properties.
4 months
Encouraging explanation to sleep, rest and receiving Lorazepam 1mg in the first night post trauma
Encouraging explanation to deprived sleep in the first night post trauma
An explanation will be given about sleep, encouraging the patient to sleep - lorazepam 1mg will be offered to promote sleep.
An explanation about sleep will be given, discouraging the patient from sleeping in the first night after the traumatic event.
Chaim Sheba Medical Center
Tel Litwinsky, 52621, Israel
Joseph Zohar, MD
Department of Psychiatry, Chaim Sheba Medical Center, Israel
First Submitted
September 5, 2012
First Posted
September 12, 2012
Study Start
October 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2014
Estimated (date passed)Examining an Emergency Room Intervention for the Prevention of Post Traumatic Stress Disorder (PTSD)
Lorazepam 1 mg
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 10, 2012
Record last verified: 2012-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: